Curabitur egestas enim non sem mollis nec dictum dui venenatis. Sed ullamcorper, risus nec suscipit dictum, libero urna bibendum ligula, vitae feugiat lacus dui pharetra sapien. Nam et velit sapien. Sed sollicitudin magna at metus vehicula non suscipit justo interdum.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas malesuada, tortor eget consectetur scelerisque, neque ligula mattis nibh, in eleifend elit velit ut est. Suspendisse fringilla tortor adipiscing nisl faucibus tristique. Curabitur ultricies diam eu ligula posuere accumsan.
Web Poll
|
Web Survey
C. Curabitur
Curabitur egestas enim non sem mollis nec dictum dui venenatis. Sed ullamcorper, risus nec suscipit dictum, libero urna bibendum ligula, vitae feugiat lacus dui pharetra sapien. Nam et velit sapien. Sed sollicitudin magna at metus vehicula non suscipit justo interdum. Phasellus ut diam magna, ac sagittis sem. Suspendisse at auctor nibh. Nulla a turpis quam, ac ullamcorper eros. Donec ut vestibulum arcu. Donec ut purus turpis, a cursus metus. Praesent congue, tellus eget pretium dapibus, tortor purus venenatis tellus, eget luctus justo lorem rutrum leo. Nulla congue, dui vel scelerisque rhoncus, magna dui blandit felis, vitae aliquam mauris eros in nulla.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More